Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
Top Cited Papers
- 1 December 2009
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 10 (12) , 1152-1159
- https://doi.org/10.1016/s1470-2045(09)70282-7
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- HIV infection and the risk of cancers with and without a known infectious causeAIDS, 2009
- Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV‐Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine CohortClinical Infectious Diseases, 2009
- Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyAIDS, 2009
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort studyAIDS, 2009
- HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAIDS, 2008
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid StructuresJournal of Clinical Oncology, 2008
- Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyBritish Journal of Cancer, 2008
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSBlood, 2006
- Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort StudyBritish Journal of Cancer, 2006
- Lung cancer in HIV infected patients: facts, questions and challengesThorax, 2006